About Ipca Laboratories
Ipca Laboratories is a company based in Mumbai (India) founded in 1949. It operates as a Reseller / Distribution. The company has 23,240 employees as of March 31, 2024. Ipca Laboratories has completed 3 acquisitions, including Bayshore Pharmaceuticals, Noble Explochem and Ramdev Chemicals. Ipca Laboratories offers products and services including APIs, Formulations, and Generics.
- Headquarter Mumbai, India
- Employees 23240 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ipca Laboratories Limited
-
Annual Revenue
$1.04 B (USD)16.23as on Mar 31, 2025
-
Net Profit
$86.38 M (USD)34.77as on Mar 31, 2025
-
EBITDA
$201.79 M (USD)49.21as on Mar 31, 2025
-
Latest Funding Round
$40 M (USD), Post-IPO
Mar 25, 2013
- Investors
-
Employee Count
23240
as on Mar 31, 2024
-
Investments & Acquisitions
Bayshore Pharmaceuticals
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ipca Laboratories
Ipca Laboratories is a publicly listed company on the NSE with ticker symbol IPCALAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Ipca Laboratories
Ipca Laboratories offers a comprehensive portfolio of products and services, including APIs, Formulations, and Generics.
Active pharmaceutical ingredients are produced for global markets.
Formulated drugs are developed for various health conditions.
Generic medicines are offered at competitive market prices.
People of Ipca Laboratories
Unlock access to complete
Unlock access to complete
Funding Insights of Ipca Laboratories
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $40.0M
-
First Round
First Round
(25 Mar 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2013 | Amount | Post-IPO - Ipca Laboratories | Valuation |
investors |
Investors in Ipca Laboratories
Ipca Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ChrysCapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focusing on private equity in sectors like financial services and healthcare.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ipca Laboratories
Ipca Laboratories has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bayshore Pharmaceuticals, Noble Explochem and Ramdev Chemicals.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of pharmaceutical products
|
2011 | ||||
|
APIs, intermediates, specialty chemicals, and custom synthesis molecules are manufactured.
|
1999 | ||||
|
Industrial chemicals and explosives are manufactured and distributed.
|
0 |
Financial Statements - Ipca Laboratories
Ipca Laboratories Comparisons
Competitors of Ipca Laboratories
Frequently Asked Questions about Ipca Laboratories
Ipca Laboratories was founded in 1949 and raised its 1st funding round 64 years after it was founded.
Ipca Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Pranay Godha is the current CEO of Ipca Laboratories.
As of Mar 31, 2024, the latest employee count at Ipca Laboratories is 23,240.
Annual revenue of Ipca Laboratories is $1.04B as on Mar 31, 2025.
Ipca Laboratories is involved in the production and distribution of active pharmaceutical ingredients (APIs), formulations, and generic medicines. The company operates within the healthcare sector, focusing on providing affordable healthcare solutions globally. Emphasis is placed on backward integration to ensure a reliable supply chain and cost competitiveness. Expansion in the generic drug space is pursued to enhance market reach. Corporate social responsibility initiatives are undertaken to support patient health, environmental sustainability, and community development.
Ipca Laboratories offers APIs, Formulations, and Generics.
Yes, Ipca Laboratories is publicly traded on NSE under the ticker symbol IPCALAB.
Ipca Laboratories has made 3 acquisitions, including Bayshore Pharmaceuticals, Noble Explochem, and Ramdev Chemicals.
Ipca Laboratories has 1 investor. Key investors include ChrysCapital.
The ticker symbol of Ipca Laboratories is IPCALAB on NSE.